NYU Langone Health

Insight regarding the recent change to aspirin guidelines and what it means for patients from platelet specialist Jeffrey Berger, MD.

Barbhaiya talks about what he considers to be misleading success rates for Afib ablation being published in studies.

Discussing the implications and future of wearable technology after the release of the Apple Heart Study.

What sort of problems will orthopedic surgeons face in the future and how has the average patient changed in recent years?

MD Magazine sat down with Chirag Barbhaiya, MD, of NYU Langone Health, to discuss the updated guidelines for treating a patient with Afib.

A sham-controlled trial demonstrated that a novel at-home administration of transcranial stimulation reduced fatigue in multiple sclerosis.

The seemingly complicated maneuvers of getting patient’s cholesterol better can be resolved with common sense. What’s best for the patient?

Since the PCSK9 inhibitors were approved for cholesterol management by the FDA in 2015, they have been frequently compared.